David Bourdon
Known title: Chief Executive OfficerCIK: 0001823690
Associated companies
Transaction History
| LFST | ▼ Sell | Gift | 150,000 | $0 | 9/22/2026 | View on chart |
| LFST | ▼ Sell | Gift | 150,000 | $0 | 9/22/2026 | View on chart |
| LFST | ▼ Sell | Gift | 150,000 | $0 | 9/22/2026 | View on chart |
| LFST | ▼ Sell | Gift | 150,000 | $0 | 9/22/2026 | View on chart |
| LFST | ▼ Sell | Other | 150,000 | $0 | 9/2/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 10,884 | $75K | 3/9/2026 | View on chart |
| LFST | ▲ Buy | Grant | 122,994 | $0 | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 51,474 | $356K | 3/9/2026 | View on chart |
| LFST | ▲ Buy | Grant | 205,550 | $0 | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 86,024 | $594K | 3/9/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 65,837 | $456K | 3/6/2026 | View on chart |
| LFST | ▲ Buy | Grant | 395,683 | $0 | 3/5/2026 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 10,884 | $77K | 3/10/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 29,685 | $225K | 3/7/2025 | View on chart |
| LFST | ▲ Buy | Grant | 124,644 | $0 | 3/7/2025 | View on chart |
| LFST | ▲ Buy | Grant | 80,906 | $0 | 3/7/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 42,816 | $325K | 3/7/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 16,767 | $132K | 3/6/2025 | View on chart |
| LFST | ▲ Buy | Grant | 348,985 | $0 | 3/6/2025 | View on chart |
| LFST | ▼ Sell | Open Market | 58,826 | $408K | 3/11/2024 | View on chart |
| LFST | ▲ Buy | Grant | 104,022 | $0 | 3/8/2024 | View on chart |
| LFST | ▲ Buy | Grant | 124,644 | $0 | 3/8/2024 | View on chart |
| LFST | ▲ Buy | Grant | 160,256 | $0 | 3/6/2023 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 77,072 | $426K | 11/10/2022 | View on chart |
| LFST | ▲ Buy | Grant | 180,832 | $0 | 11/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.